| Followers | 0 |
| Posts | 6673 |
| Boards Moderated | 0 |
| Alias Born | 01/28/2011 |
Wednesday, January 11, 2012 6:13:47 PM
If it had just been a pullback, I would agree 100% with you and ClayTrader. You both have far more experience than me and I would glady defer to your expertise. However, we all of a sudden had at least a dozen negative posters show up, many of whom had never posted on ATRN before and start giving doomsday predictions and crying TIMMMMBBBEERRRRR. There was definitely some coordination and choreographing going on here.
I agree, smart and disciplined traders set targets and stick to them. Today's highs would have represented 400% gains for those who got in around a penny, and a double for those who got in around .025. No problem with profit taking. I applaud it. But, after we had only seen one or two negative posters for weeks, for a dozen to show up at the exact same time with the exact same posts was a little bit uncanny. Do you disagree?
All IMHO. I'm just glad we closed green and hope too many people didn't get scared out or lose money.
I agree, smart and disciplined traders set targets and stick to them. Today's highs would have represented 400% gains for those who got in around a penny, and a double for those who got in around .025. No problem with profit taking. I applaud it. But, after we had only seen one or two negative posters for weeks, for a dozen to show up at the exact same time with the exact same posts was a little bit uncanny. Do you disagree?
All IMHO. I'm just glad we closed green and hope too many people didn't get scared out or lose money.
If you have patience, follow me to Patient Profitable Picks:
http://investorshub.advfn.com/boards/board.aspx?board_id=23041
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
